|
| 37556401 | Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study. | Inflamm Bowel Dis | 2024 |
| 38015321 | Comparative Persistence of Non-tumor Necrosis Factor (TNF) vs. TNF Antagonists for Post-operative Prophylaxis in Crohn's Disease (CD). | Dig Dis Sci | 2024 |
| 36343846 | Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort Study. | Clin Gastroenterol Hepatol | 2023 |
| 37898112 | Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot Study. | Inflamm Bowel Dis | 2023 |
| 37610821 | Web-Based Video Education to Improve Uptake of Influenza Vaccination and Other Preventive Health Recommendations in Adults With Inflammatory Bowel Disease: Randomized Controlled Trial of Project PREVENT. | J Med Internet Res | 2023 |
| 37773982 | Postvaccination Symptoms After a Fourth Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2023 |
| 37499955 | Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. | Gastroenterology | 2023 |
| 37762524 | A Paratope-Enhanced Method to Determine Breadth and Depth TCR Clonal Metrics of the Private Human T-Cell Vaccine Response after SARS-CoV-2 Vaccination. | Int J Mol Sci | 2023 |
| 35648151 | Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib. | Inflamm Bowel Dis | 2023 |
| 35644340 | Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. | Clin Gastroenterol Hepatol | 2023 |
| 35640124 | Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study. | Inflamm Bowel Dis | 2023 |
| 36989446 | Economic burden related to fistulas or strictures among commercially insured patients with Crohn's disease in the United States. | J Manag Care Spec Pharm | 2023 |
| 37080587 | Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. | Gut | 2023 |
| 37207314 | Patients With Inflammatory Bowel Diseases and Higher Visceral Adipose Tissue Burden May Benefit From Higher Infliximab Concentrations to Achieve Remission. | Am J Gastroenterol | 2023 |
| 36998249 | Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis. | Crohns Colitis 360 | 2023 |
| 36625223 | Long-term durability of antibody responses after SARS-CoV-2 vaccination and influencing factors. | J Intern Med | 2023 |
| 36476714 | Inflammatory Bowel Disease Patients' Preferences for Subcutaneous versus Intravenous Therapies: A Mixed-Methods Study. | Dig Dis | 2023 |
| 36512266 | Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn's Disease in Remission on Infliximab and Azathioprine. | Dig Dis Sci | 2023 |
| 36280102 | Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab. | Clin Gastroenterol Hepatol | 2023 |
| 36179129 | Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment. | Inflamm Bowel Dis | 2023 |
| 35998072 | Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD. | Inflamm Bowel Dis | 2023 |
| 36377259 | Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. | Aliment Pharmacol Ther | 2023 |
| 34037211 | Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process. | Inflamm Bowel Dis | 2022 |
| 35613792 | Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis. | BMJ Open | 2022 |
| 35765315 | Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. | Open Forum Infect Dis | 2022 |
| 35397000 | The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy. | Inflamm Bowel Dis | 2022 |
| 35464463 | Differences in SARS-CoV-2 Vaccine Response Dynamics Between Class-I- and Class-II-Specific T-Cell Receptors in Inflammatory Bowel Disease. | Front Immunol | 2022 |
| 36777042 | Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection. | Crohns Colitis 360 | 2022 |
| 35973146 | Interactive Inflammatory Bowel Disease Biologics Decision Aid Does Not Improve Patient Outcomes Over Static Education: Results From a Randomized Trial. | Am J Gastroenterol | 2022 |
| 35973139 | Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study. | Am J Gastroenterol | 2022 |
| 35971134 | Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome. | Genome Med | 2022 |
| 36300960 | Treat-to-Target: The Era of Targeted Immunosuppressive Agents in IBD Management. | R I Med J (2013) | 2022 |
| 35069032 | Acute Severe Colitis: The Need for Joint Management between Gastroenterologists and Surgeons. | Clin Colon Rectal Surg | 2022 |
| 35006492 | Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology. | Dig Dis Sci | 2022 |
| 34893849 | Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study. | Inflamm Bowel Dis | 2022 |
| 34481951 | Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review. | Clin Gastroenterol Hepatol | 2022 |
| 34798503 | Ultraviolet-A light increases mitochondrial anti-viral signaling protein in confluent human tracheal cells via cell-cell signaling. | J Photochem Photobiol B | 2022 |
| 34350943 | Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease. | J Crohns Colitis | 2022 |
| 32170473 | Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis. | Dig Dis Sci | 2021 |
| 33821287 | Adverse Events Following SARS-CoV-2 mRNA Vaccination Among Patients with Inflammatory Bowel Disease. | medRxiv | 2021 |
| 33617891 | Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines. | Gastroenterology | 2021 |
| 33529314 | Ulcerative Colitis Narrative Global Survey Findings: The Impact of Living With Ulcerative Colitis-Patients' and Physicians' View. | Inflamm Bowel Dis | 2021 |
| 33831380 | Reply. | Gastroenterology | 2021 |
| 34909797 | Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease. | medRxiv | 2021 |
| 34909785 | The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders. | medRxiv | 2021 |
| 34849970 | Point-of-care dashboards promote coproduction of healthcare services for patients with inflammatory bowel disease. | Int J Qual Health Care | 2021 |
| 34965855 | Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection. | J Transl Med | 2021 |
| 34759001 | Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer. | Cancer Res | 2021 |
| 34633830 | Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease. | Ann Intern Med | 2021 |
| 34516445 | Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease. | Dis Colon Rectum | 2021 |